Clinical application of brain imaging for the diagnosis of mood disorders: The current state of play

Molecular Psychiatry

Volumn 18, Issue 5, 2013, Pages 528-539

  Savitz, J B ^a,b   Rauch, S L ^c,d   Drevets, W C ^a,e  

^a LAUREATE INSTITUTE FOR BRAIN RESEARCH   (United States)

^b UNIVERSITY OF TULSA   (United States)

^c MCLEAN HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e JOHNSON AND JOHNSON   (United States)

Author keywords

biomarker; depression; diagnosis; mood disorders; MRI; neuroimaging

Indexed keywords

4 AMINOBUTYRIC ACID; AMYLOID BETA PROTEIN; FLORBETAPIR F 18; GLUTAMIC ACID; GLUTAMINE; PHARMACOLOGICAL BIOMARKER; SEROTONIN 1A RECEPTOR; BIOLOGICAL MARKER;

ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ANHEDONIA; ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; BRAIN SIZE; COGNITIVE THERAPY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; EVIDENCE BASED MEDICINE; FAMILY HISTORY; FOOD AND DRUG ADMINISTRATION; FRACTIONAL ANISOTROPY; GENETIC RISK; GENETIC VARIABILITY; GLUCOSE METABOLISM; HISTOPATHOLOGY; HUMAN; LUNG CANCER; MAJOR DEPRESSION; MIDDLE FRONTAL GYRUS; MOOD DISORDER; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEUS ACCUMBENS; OCCIPITAL CORTEX; ORBITAL CORTEX; POSTERIOR CINGULATE; PREDICTIVE VALUE; PRIORITY JOURNAL; REMISSION; REVIEW; SENSITIVITY AND SPECIFICITY; SIGNAL NOISE RATIO; SMOKING; STANDARD; THORAX RADIOGRAPHY; TREATMENT OUTCOME; TREATMENT RESPONSE; BRAIN; METABOLISM; MOOD DISORDERS; PATHOLOGY; PROCEDURES; REPRODUCIBILITY; SCINTISCANNING; STANDARDS; UNITED STATES;

BIOLOGICAL MARKERS; BRAIN; EVIDENCE-BASED MEDICINE; HUMANS; MOOD DISORDERS; NEUROIMAGING; REPRODUCIBILITY OF RESULTS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84876675969     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2013.25     Document Type: Review

References (111)

1. De Gruttola VG, Clax P, DeMets DL, Downing GJ, Ellenberg SS, Friedman L et al. Considerations in the evaluation of surrogate endpoints in clinical trials. summary of a National Institutes of Health workshop. Control Clin Trials 2001; 22: 485-502.
2. Mayeux R. Evaluation and use of diagnostic tests in Alzheimer's disease. Neu-robiol Aging 1998; 19: 139-143.
3. 00. The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association and the National Institute on Aging Working Group. Neurobiol Aging 1998; 19: 109-116.
4. Clark CM, Schneider JA, Bedell BJ, Beach TG, Bilker WB, Mintun MA et al. Use of florbetapir-PET for imaging beta-amyloid pathology. Jama 2011; 305: 275-283.
5. Lilienfeld AM, Kordan B. A study of variability in the interpretation of chest x-rays in the detection of lung cancer. Cancer Res 1966; 26: 2145-2147.
6. APA. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). APA Press: Washington, D.C., 1994.
7. Savitz JB, Drevets WC. Imaging phenotypes of major depressive disorder: genetic correlates. Neuroscience 2009; 164: 300-330.
8. Hasler G, Northoff G. Discovering imaging endophenotypes for major depression. Mol Psychiatry 2011; 16: 604-619.
9. Delvecchio G, Fossati P, Boyer P, Brambilla P, Falkai P, Gruber O et al. Common and distinct neural correlates of emotional processing in Bipolar Disorder and Major Depressive Disorder: a voxel-based meta-analysis of functional magnetic resonance imaging studies. Eur Neuropsychopharmacol 2012; 22: 100-113.
10. Yuksel C, Ongur D. Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders. Biol Psychiatry 2010; 68: 785-794.
11. Savitz J, Drevets WC. Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide. Neurosci Biobehav Rev 2009; 33: 699-771.
12. Savitz JB, Drevets WC. Neuroreceptor imaging in depression. Neurobiol Dis 2013; 52: 49-65.
13. Strakowski SM, Adler CM, Almeida J, Altshuler LL, Blumberg HP, Chang KD et al. The functional neuroanatomy of bipolar disorder: a consensus model. Bipolar Disord 2012; 14: 313-325.
14. Sheline YI, Barch DM, Donnelly JM, Ollinger JM, Snyder AZ, Mintun MA. Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study. Biol Psychiatry 2001; 50: 651-658.
15. Victor TA, Furey ML, Fromm SJ, Ohman A, Drevets WC. Relationship between amygdala responses to masked faces and mood state and treatment in major depressive disorder. Arch Gen Psychiatry 2010; 67: 1128-1138.
16. Victor TA, Furey ML, Fromm SJ, Bellgowan PS, Ohman A, Drevets WC. The extended functional neuroanatomy of emotional processing biases for masked faces in major depressive disorder. PLoS One 2012; 7: e46439.
17. Suslow T, Konrad C, Kugel H, Rumstadt D, Zwitserlood P, Schoning S et al. Automatic mood-congruent amygdala responses to masked facial expressions in major depression. Biol Psychiatry 2010; 67: 155-160.
18. Siegle GJ, Thompson W, Carter CS, Steinhauer SR, Thase ME. Increased amygdala and decreased dorsolateral prefrontal BOLD responses in unipolar depression: related and independent features. Biol Psychiatry 2007; 61: 198-209.
19. Robinson OJ, Cools R, Carlisi CO, Sahakian BJ, Drevets WC. Ventral striatum response during reward and punishment reversal learning in unmedicated major depressive disorder. Am J Psychiatry 2012; 169: 152-159.
20. Der-Avakian A, Markou A. The neurobiology of anhedonia and other reward-related deficits. Trends Neurosci 2012; 35: 68-77.
21. Keedwell PA, Andrew C, Williams SC, Brammer MJ, Phillips ML. The neural correlates of anhedonia in major depressive disorder. Biol Psychiatry 2005; 58: 843-853.
22. Epstein J, Pan H, Kocsis JH, Yang Y, Butler T, Chusid J et al. Lack of ventral striatal response to positive stimuli in depressed versus normal subjects. Am J Psychiatry 2006; 163: 1784-1790.
23. Pizzagalli DA, Iosifescu D, Hallett LA, Ratner KG, Fava M. Reduced hedonic capacity in major depressive disorder: evidence from a probabilistic reward task. J Psychiatr Res 2008; 43: 76-87.
24. Treadway MT, Zald DH. Reconsidering anhedonia in depression: lessons from translational neuroscience. Neurosci Biobehav Rev 2011; 35: 537-555.
25. Pizzagalli DA, Holmes AJ, Dillon DG, Goetz EL, Birk JL, Bogdan R et al. Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder. Am J Psychiatry 2009; 166: 702-710.
26. Gottesman, II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions Am J Psychiatry 2003; 160: 636-645.
27. Monk CS, Klein RG, Telzer EH, Schroth EA, Mannuzza S, Moulton 3rd JL et al. Amygdala and nucleus accumbens activation to emotional facial expressions in children and adolescents at risk for major depression. Am J Psychiatry 2008; 165: 90-98.
28. Olsavsky AK, Brotman MA, Rutenberg JG, Muhrer EJ, Deveney CM, Fromm SJ et al. Amygdala hyperactivation during face emotion processing in unaffected youth at risk for bipolar disorder. J Am Acad Child Adolesc Psychiatry 2012; 51: 294-303.
29. Gotlib IH, Hamilton JP, Cooney RE, Singh MK, Henry ML, Joormann J. Neural processing of reward and loss in girls at risk for major depression. Arch Gen Psychiatry 2010; 67: 380-387.
30. McCabe C, Woffindale C, Harmer CJ, Cowen PJ. Neural processing of reward and punishment in young people at increased familial risk of depression. Biol Psychiatry 2012; 72: 588-594.
31. Drevets WC, Savitz J, Trimble M. The subgenual anterior cingulate cortex in mood disorders. CNS Spectr 2008; 13: 663-681.
32. Bora E, Harrison BJ, Davey CG, Yucel M, Pantelis C. Meta-analysis of volumetric abnormalities in cortico-striatal-pallidal-thalamic circuits in major depressive disorder. Psychol Med 2012; 42: 671-681.
33. Hajek T, Kozeny J, Kopecek M, Alda M, Hoschl C. Reduced subgenual cingulate volumes in mood disorders: a meta-analysis. J Psychiatry Neurosci 2008; 33: 91-99.
34. Koolschijn PC, van Haren NE, Lensvelt-Mulders GJ, Hulshoff Pol HE, Kahn RS. Brain volume abnormalities in major depressive disorder: a meta-analysis of magnetic resonance imaging studies. Hum Brain Mapp 2009; 30: 3719-3735.
35. Arnone D, McIntosh AM, Ebmeier KP, Munafo MR, Anderson IM. Magnetic resonance imaging studies in unipolar depression: systematic review and metaregression analyses. Eur Neuropsychopharmacol 2012; 22: 1-16.
36. Kempton MJ, Salvador Z, Munafo MR, Geddes JR, Simmons A, Frangou S et al. Structural neuroimaging studies in major depressive disorder. Meta-analysis and comparison with bipolar disorder. Arch Gen Psychiatry 2011; 68: 675-690.
37. Hafeman DM, Chang KD, Garrett AS, Sanders EM, Phillips ML. Effects of medication on neuroimaging findings in bipolar disorder: an updated review. Bipolar Disord 2012; 14: 375-410.
38. Moore GJ, Bebchuk JM, Wilds IB, Chen G, Manji HK. Lithium-induced increase in human brain grey matter. Lancet 2000; 356: 1241-1242.
39. Moore GJ, Cortese BM, Glitz DA, Zajac-Benitez C, Quiroz JA, Uhde TW et al. A longitudinal study of the effects of lithium treatment on prefrontal and sub-genual prefrontal gray matter volume in treatment-responsive bipolar disorder patients. J Clin Psychiatry 2009; 70: 699-705.
40. Savitz J, Nugent AC, Bogers W, Liu A, Sills R, Luckenbaugh DA et al. Amygdala volume in depressed patients with bipolar disorder assessed using high resolution 3T MRI: the impact of medication. Neuroimage 2010; 49: 2966-2976.
41. Savitz JB, Nugent AC, Bogers W, Roiser JP, Bain EE, Neumeister A et al. Habenula volume in bipolar disorder and major depressive disorder: a high-resolution magnetic resonance imaging study. Biol Psychiatry 2011; 69: 336-343.
42. Chen MC, Hamilton JP, Gotlib IH. Decreased hippocampal volume in healthy girls at risk of depression. Arch Gen Psychiatry 2010; 67: 270-276.
43. Carballedo A, Lisiecka D, Fagan A, Saleh K, Ferguson Y, Connolly G et al. Early life adversity is associated with brain changes in subjects at family risk for depression. World J Biol Psychiatry 2012; 13: 569-578.
44. Boes AD, McCormick LM, Coryell WH, Nopoulos P. Rostral anterior cingulate cortex volume correlates with depressed mood in normal healthy children. Biol Psychiatry 2008; 63: 391-397.
45. Glahn DC, Curran JE, Winkler AM, Carless MA, Kent Jr. JW, Charlesworth JC et al. High dimensional endophenotype ranking in the search for major depression risk genes. Biol Psychiatry 2012; 71: 6-14.
46. McDonald C, Bullmore ET, Sham PC, Chitnis X, Wickham H, Bramon E et al. Association of genetic risks for schizophrenia and bipolar disorder with specific and generic brain structural endophenotypes. Arch Gen Psychiatry 2004; 61: 974-984.
47. Stockmeier CA, Mahajan GJ, Konick LC, Overholser JC, Jurjus GJ, Meltzer HY et al. Cellular changes in the postmortem hippocampus in major depression. Biol Psychiatry 2004; 56: 640-650.
48. Ongur D, Drevets WC, Price JL. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci USA 1998; 95: 13290-13295.
49. Price JL, Drevets WC. Neurocircuitry of mood disorders. Neuropsychopharma-cology 2010; 35: 192-216.
50. Taylor MJ, Selvaraj S, Norbury R, Jezzard P, Cowen PJ. Normal glutamate but elevated myo-inositol in anterior cingulate cortex in recovered depressed patients. J Affect Disord 2009; 119: 186-189.
51. Hasler G, van der Veen JW, Tumonis T, Meyers N, Shen J, Drevets WC. Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. Arch Gen Psychiatry 2007; 64: 193-200.
52. Sanacora G, Mason GF, Rothman DL, Behar KL, Hyder F, Petroff OA et al. Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch Gen Psychiatry 1999; 56: 1043-1047.
53. Gabbay V, Mao X, Klein RG, Ely BA, Babb JS, Panzer AM et al. Anterior cingulate cortex gamma-aminobutyric acid in depressed adolescents: relationship to anhedonia. Arch Gen Psychiatry 2012; 69: 139-149.
54. Sheline YI, Barch DM, Price JL, Rundle MM, Vaishnavi SN, Snyder AZ et al. The default mode network and self-referential processes in depression. Proc Natl Acad Sci USA 2009; 106: 1942-1947.
55. Northoff G, Wiebking C, Feinberg T, Panksepp J. The 'resting-state hypothesis' of major depressive disorder-a translational subcortical-cortical framework for a system disorder. Neurosci Biobehav Rev 2011; 35: 1929-1945.
56. Sheline YI, Price JL, Yan Z, Mintun MA. Resting-state functional MRI in depression unmasks increased connectivity between networks via the dorsal nexus. Proc Natl Acad Sci USA 2010; 107: 11020-11025.
57. Greicius MD, Flores BH, Menon V, Glover GH, Solvason HB, Kenna H et al. Resting-state functional connectivity in major depression: abnormally increased contributions from subgenual cingulate cortex and thalamus. Biol Psychiatry 2007; 62: 429-437.
58. Pizzagalli DA. Frontocingulate dysfunction in depression: toward biomarkers of treatment response. Neuropsychopharmacology 2011; 36: 183-206.
59. Alexopoulos GS, Meyers BS, Young RC, Campbell S, Silbersweig D, Charlson M. 'Vascular depression' hypothesis. Arch Gen Psychiatry 1997; 54: 915-922.
60. Krishnan KR, Hays JC, Blazer DG. MRI-defined vascular depression. Am J Psychiatry 1997; 154: 497-501.
61. Botteron KN, Vannier MW, Geller B, Todd RD, Lee BC. Preliminary study of magnetic resonance imaging characteristics in 8-to 16-year-olds with mania. J Am Acad Child Adolesc Psychiatry 1995; 34: 742-749.
62. McDonald WM, Tupler LA, Marsteller FA, Figiel GS, DiSouza S, Nemeroff CB et al. Hyperintense lesions on magnetic resonance images in bipolar disorder. Biol Psychiatry 1999; 45: 965-971.
63. Lyoo IK, Lee HK, Jung JH, Noam GG, Renshaw PF. White matter hyperintensities on magnetic resonance imaging of the brain in children with psychiatric disorders. Compr Psychiatry 2002; 43: 361-368.
64. Versace A, Almeida JR, Hassel S, Walsh ND, Novelli M, Klein CR et al. Elevated left and reduced right orbitomedial prefrontal fractional anisotropy in adults with bipolar disorder revealed by tract-based spatial statistics. Arch Gen Psychiatry 2008; 65: 1041-1052.
65. Beyer JL, Taylor WD, MacFall JR, Kuchibhatla M, Payne ME, Provenzale JM et al. Cortical white matter microstructural abnormalities in bipolar disorder. Neu-ropsychopharmacology 2005; 30: 2225-2229.
66. Adler CM, Holland SK, Schmithorst V, Wilke M, Weiss KL, Pan H et al. Abnormal frontal white matter tracts in bipolar disorder: a diffusion tensor imaging study. Bipolar Disord 2004; 6: 197-203.
67. Houenou J, Wessa M, Douaud G, Leboyer M, Chanraud S, Perrin M et al. Increased white matter connectivity in euthymic bipolar patients: diffusion tensor tractography between the subgenual cingulate and the amygdalo-hip- pocampal complex. Mol Psychiatry 2007; 12: 1001-1010.
68. Lu LH, Zhou XJ, Fitzgerald J, Keedy SK, Reilly JL, Passarotti AM et al. Microstructural abnormalities of white matter differentiate pediatric and adult-onset bipolar disorder. Bipolar Disord 2012; 14: 597-606.
69. Vederine FE, Wessa M, Leboyer M, Houenou J. A meta-analysis of whole-brain diffusion tensor imaging studies in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 2011; 35: 1820-1826.
70. Liao Y, Huang X, Wu Q, Yang C, Kuang W, Du M et al. Is depression a disconnection syndrome? Meta-analysis of diffusion tensor imaging studies in patients with MDD. J Psychiatry Neurosci 2012; 37: 110180.
71. Zhu X, Wang X, Xiao J, Zhong M, Liao J, Yao S. Altered white matter integrity in first-episode, treatment-naive young adults with major depressive disorder: a tract-based spatial statistics study. Brain Res 2011; 1369: 223-229.
72. Cullen KR, Klimes-Dougan B, Muetzel R, Mueller BA, Camchong J, Houri A et al. Altered white matter microstructure in adolescents with major depression: a preliminary study. J Am Acad Child Adolesc Psychiatry 2010; 49: 173-183 e171.
73. Anand A, Li Y, Wang Y, Wu J, Gao S, Bukhari L et al. Activity and connectivity of brain mood regulating circuit in depression: a functional magnetic resonance study. Biol Psychiatry 2005; 57: 1079-1088.
74. Chen CH, Suckling J, Ooi C, Fu CH, Williams SC, Walsh ND et al. Functional coupling of the amygdala in depressed patients treated with antidepressant medication. Neuropsychopharmacology 2008; 33: 1909-1918.
75. Gulseren S, Gurcan M, Gulseren L, Gelal F, Erol A. T2 hyperintensities in bipolar patients and their healthy siblings. Arch Med Res 2006; 37: 79-85.
76. Gunde E, Novak T, Kopecek M, Schmidt M, Propper L, Stopkova P et al. White matter hyperintensities in affected and unaffected late teenage and early adulthood offspring of bipolar parents: a two-center high-risk study. J Psychiatr Res 2011; 45: 76-82.
77. Frazier JA, Breeze JL, Papadimitriou G, Kennedy DN, Hodge SM, Moore CM et al. White matter abnormalities in children with and at risk for bipolar disorder. Bipolar Disord 2007; 9: 799-809.
78. Versace A, Ladouceur CD, Romero S, Birmaher B, Axelson DA, Kupfer DJ et al. Altered development of white matter in youth at high familial risk for bipolar disorder: a diffusion tensor imaging study. J Am Acad Child Adolesc Psychiatry 2010; 49: 1249-1259 1259 e1241.
79. Mahon K, Burdick KE, Ikuta T, Braga RJ, Gruner P, Malhotra AK et al. Abnormal temporal lobe white matter as a biomarker for genetic risk of bipolar disorder. Biol Psychiatry 2013; 73: 177-182.
80. Sprooten E, Sussmann JE, Clugston A, Peel A, McKirdy J, Moorhead TW et al. White matter integrity in individuals at high genetic risk of bipolar disorder. Biol Psychiatry 2011; 70: 350-356.
81. Keedwell PA, Chapman R, Christiansen K, Richardson H, Evans J, Jones DK. Cingulum white matter in young women at risk of depression: the effect of family history and anhedonia. Biol Psychiatry 2012; 72: 296-302.
82. Huang H, Fan X, Williamson DE, Rao U. White matter changes in healthy adolescents at familial risk for unipolar depression: a diffusion tensor imaging study. Neuropsychopharmacology 2011; 36: 684-691.
83. Hirvonen J, Karlsson H, Kajander J, Lepola A, Markkula J, Rasi-Hakala H et al. Decreased brain serotonin 5-HT1A receptor availability in medication-naive patients with major depressive disorder: an in-vivo imaging study using PET and [carbonyl-11C]WAY-100635. Int J Neuropsychopharmacol 2008; 11: 465-476.
84. Bhagwagar Z, Rabiner EA, Sargent PA, Grasby PM, Cowen PJ. Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635. Mol Psychiatry 2004; 9: 386-392.
85. Drevets WC, Frank E, Price JC, Kupfer DJ, Greer PJ, Mathis C. Serotonin type-1A receptor imaging in depression. Nucl Med Biol 2000; 27: 499-507.
86. Drevets WC, Thase ME, Moses-Kolko EL, Price J, Frank E, Kupfer DJ et al. Ser-otonin-1A receptor imaging in recurrent depression: replication and literature review. Nucl Med Biol 2007; 34: 865-877.
87. Sargent PA, Kjaer KH, Bench CJ, Rabiner EA, Messa C, Meyer J et al. Brain ser-otonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. Arch Gen Psychiatry 2000; 57: 174-180.
88. Drevets WC, Frank E, Price JC, Kupfer DJ, Holt D, Greer PJ et al. PET imaging of serotonin 1A receptor binding in depression. Biol Psychiatry 1999; 46: 1375-1387.
89. Cannon DM, Ichise M, Rollis D, Klaver JM, Gandhi SK, Charney DS et al. Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorder. Biol Psychiatry 2007; 62: 870-877.
90. Cannon DM, Ichise M, Fromm SJ, Nugent AC, Rollis D, Gandhi SK et al. Serotonin transporter binding in bipolar disorder assessed using [11C]DASB and positron emission tomography. Biol Psychiatry 2006; 60: 207-217.
91. Parsey RV, Olvet DM, Oquendo MA, Huang YY, Ogden RT, Mann JJ. Higher 5-HT1A receptor binding potential during a major depressive episode predicts poor treatment response: preliminary data from a naturalistic study. Neuropsychopharmacology 2006; 31: 1745-1749.
92. Parsey RV, Hastings RS, Oquendo MA, Huang YY, Simpson N, Arcement J et al. Lower serotonin transporter binding potential in the human brain during major depressive episodes. Am J Psychiatry 2006; 163: 52-58.
93. Chen Y, Parrish TB. Caffeine's effects on cerebrovascular reactivity and coupling between cerebral blood flow and oxygen metabolism. Neuroimage 2009; 44: 647-652.
94. Hahn B, Ross TJ, Yang Y, Kim I, Huestis MA, Stein EA. Nicotine enhances visuospatial attention by deactivating areas of the resting brain default network. J Neurosci 2007; 27: 3477-3489.
95. Bruehl H, Wolf OT, Sweat V, Tirsi A, Richardson S, Convit A. Modifiers of cognitive function and brain structure in middle-aged and elderly individuals with type 2 diabetes mellitus. Brain Res 2009; 1280: 186-194.
96. Meyer JH, McNeely HE, Sagrati S, Boovariwala A, Martin K, Verhoeff NP et al. Elevated putamen D(2) receptor binding potential in major depression with motor retardation: an [11C]raclopride positron emission tomography study. Am J Psychiatry 2006; 163: 1594-1602.
97. Erritzoe D, Frokjaer VG, Haahr MT, Kalbitzer J, Svarer C, Holst KK et al. Cerebral serotonin transporter binding is inversely related to body mass index. Neuroimage 2010; 52: 284-289.
98. Praschak-Rieder N, Willeit M, Wilson AA, Houle S, Meyer JH. Seasonal variation in human brain serotonin transporter binding. Arch Gen Psychiatry 2008; 65: 1072-1078.
99. Walsh BT, Seidman SN, Sysko R, Gould M. Placebo response in studies of major depression: variable, substantial, and growing. Jama 2002; 287: 1840-1847.
100. Rief W, Nestoriuc Y, Weiss S, Welzel E, Barsky AJ, Hofmann SG. Meta-analysis of the placebo response in antidepressant trials. J Affect Disord 2009; 118: 1-8.
101. Sun D, van Erp TG, Thompson PM, Bearden CE, Daley M, Kushan L et al. Elucidating a magnetic resonance imaging-based neuroanatomic biomarker for psychosis: classification analysis using probabilistic brain atlas and machine learning algorithms. Biol Psychiatry 2009; 66: 1055-1060.
102. Fu CH, Mourao-Miranda J, Costafreda SG, Khanna A, Marquand AF, Williams SC et al. Pattern classification of sad facial processing: toward the development of neurobiological markers in depression. Biol Psychiatry 2008; 63: 656-662.
103. Marquand AF, Mourao-Miranda J, Brammer MJ, Cleare AJ, Fu CH. Neuroanatomy of verbal working memory as a diagnostic biomarker for depression. Neuroreport 2008; 19: 1507-1511.
104. 00 hemodynamic brain modes discriminate between schizophrenia and bipolar disorder. Hum Brain Mapp 2008; 29: 1265-1275.
105. Hahn T, Marquand AF, Ehlis AC, Dresler T, Kittel-Schneider S, Jarczok TA et al. Integrating neurobiological markers of depression. Arch Gen Psychiatry 2011; 68: 361-368.
106. Mourao-Miranda J, Oliveira L, Ladouceur CD, Marquand A, Brammer M, Birmaher B et al. Pattern recognition and functional neuroimaging help to discriminate healthy adolescents at risk for mood disorders from low risk adolescents. PLoS One 2012; 7: e29482.
107. Costafreda SG, Chu C, Ashburner J, Fu CH. Prognostic and diagnostic potential of the structural neuroanatomy of depression. PLoS One 2009; 4: e6353.
108. Gong Q, Wu Q, Scarpazza C, Lui S, Jia Z, Marquand A et al. Prognostic prediction of therapeutic response in depression using high-field MR imaging. Neuroimage 2011; 55: 1497-1503.
109. Costafreda SG, Khanna A, Mourao-Miranda J, Fu CH. Neural correlates of sad faces predict clinical remission to cognitive behavioural therapy in depression. Neuroreport 2009; 20: 637-641.
110. Insel T, Cuthbert B, Garvey M, Heinssen R, Pine DS, Quinn K et al. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry 2010; 167: 748-751.
111. Savitz JB, Bonne O, Nugent AC, Vythilingam M, Bogers W, Charney DS et al. Habenula volume in post-traumatic stress disorder measured with high-resolution MRI. Biol Mood Anxiety Disord 2011; 1: 7.